1. The stromal part of adenocarcinomas of the oesophagus: Does it conceal targets for therapy?
- Author
-
Johanna W. van Sandick, Henk H. Hartgrink, Michel W.J.M. Wouters, Marijn Takkenberg, Vincent T.H.B.M. Smit, Tom M. Karsten, Jan M.C. Junggeburt, Ewout F.W. Courrech Staal, Juliette M.J. Spitzer-Naaykens, Rob A. E. M. Tollenaar, and Wilma E. Mesker
- Subjects
Oncology ,Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Stromal cell ,Esophageal Neoplasms ,Colorectal cancer ,Adenocarcinoma ,Adenocarcinoma Disease-free survival Oesophageal neoplasms Oesophagectomy Stromal cells Surgery Survival lymph-node status prognostic-factors tumor-stroma gastroesophageal junction barretts adenocarcinoma cancer carcinoma survival progression stage ,Nodal status ,Internal medicine ,medicine ,Humans ,Stage (cooking) ,Lymph node ,Cancer staging ,Aged ,Neoplasm Staging ,Aged, 80 and over ,business.industry ,fungi ,Cell Differentiation ,Middle Aged ,medicine.disease ,Prognosis ,Cancer registry ,Esophagectomy ,medicine.anatomical_structure ,Treatment Outcome ,Lymphatic Metastasis ,Female ,Radiology ,Stromal Cells ,business ,Epidemiologic Methods - Abstract
Objective: To evaluate the prognostic value of the tumour stroma ratio (TSR) in resected adenocarcinoma of the oesophagus. Background: In the literature, a refinement of oesophageal cancer staging has been proposed. Recently, TSR has been identified as a histological characteristic of the tumour itself that proved to be a strong predictor for survival in colorectal cancer. Methods: in our cancer registry database, we identified 93 consecutive patients who underwent resection for oesophageal adenocarcinoma between 1990 and 2004 in two hospitals in our region. Using a predefined histopathological protocol, TSR was determined on the original haematoxylin-eosin (H&E) tissue sections of oesophagectomy specimens by two independent investigators. Results: With a cut-off value of 50% tumour/stroma, patients were classified as TSR high (n = 60) or TSR low (n = 33). There were no significant differences in patient, tumour and treatment characteristics between the two groups, except for M status (M1a) and radicality of resection. The (disease-free) survival in the TSR high group was significantly better than in the TSR low group. By multivariate analysis, TSR was identified as a highly significant prognostic factor for overall survival (HR 2.0; P = 0.010), independent of depth of tumour invasion, nodal status, lymph node ratio, extracapsular involvement, TNM stage, histological grade and radicality of resection. Conclusion: TSR is a new and practicable prognostic tumour characteristic for oesophageal adenocarcinoma that can discriminate patients with a poor outcome from those with a better outcome. (C) 2009 Elsevier Ltd. All rights reserved.
- Published
- 2010
- Full Text
- View/download PDF